Abstract Douglas E. Paull1, Kevin Kelley2, Jazbieh Moezzi3, Madhavi Kadakia2,4, and Steven J. Berberich2,4
Departments of 1Surgery, 2Biochemistry & Molecular Biology, 3Pathology, and the 4Center of Genomics Research. Wright State University, Boonshoft School of Medicine, and VA Medical Center, Dayton, Ohio.
Abstract: Gene expression profiles from DNA microarrays can provide molecular signatures that improve tumor classification, prognosis, and treatment options. While much of this work has focused on isolation of RNA from the resected tumor, fewer studies have utilized RNA from fine needle aspirates (FNA). In this pilot study we examined whether the gene signatures obtained from FNA samples would correlate with signatures taken from the resected tumor. Based on NSCLC gene expression profiles obtained from eleven sets of FNA and tumor samples we obtained a high concordance of FNA profiles matching their matched tumor sample. These results suggest that FNA samples may provide informative gene expression signatures regarding the potential aggressiveness of non-small-cell lung carcinomas.
Discussion
No comments yet...Be the first to comment.
I had an excellent experience publishing our review article in Clinical Medicine Reviews. The managing editor was very helpful and the process was very timely and transparent.Professor Jonathan A. Bernstein (University of Cincinnati College of Medicine, Division of Immunology, Allergy Section, Cincinnati, OH, USA) What our authors say
Copyright © 2010 Libertas Academica Ltd (except open access articles and accompanying metadata and supplementary files.)